
Retail’s last barbarian takes on Walgreens Boots
A private equity firm confronts an ailing pharmacy business with its own set of distinct obstacles
Full Article
A private equity firm confronts an ailing pharmacy business with its own set of distinct obstacles
Full ArticleSycamore Partners’ $24bn buyout of Walgreens Boots follows a playbook few now dare to use